Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | 5-allyl-5-(4-bromophenyl)-5H-imidazo[2,1-a]isoindole | HCID 46205609 | — |
| Catalyst | Osmium Tetroxide | HCID 30318 | — |
| Solvent | Acetone | HCID 180 | — |
| Product | HCID 58415410 | HCID 58415410 | — |
Reaction Steps
To a solution of 5-allyl-5-(4-bromophenyl)-5H-imidazo[2,1-a]isoindole (150 mg) in acetone (5.5 mL) was added water (1 mL) followed by NMO (60 mg) and OsO4 (0.536 mL, 2.5% in tert-BuOH). After stirring at room temperature for 24 h, 100 mg NMO and 0.1 mL OsO4 solution were added. After 9 h 0.1 mL more OsO4 solution was added and stirred at room temperature over the weekend. The reaction was then quenched with 1:1 aqueous saturated NaHCO3:Na2SO3 and partitioned between aqueous saturated NaHCO3 and EtOAc. Aqueous layer was extracted with EtOAc (3×). Combined organic layers were dried over Na2SO4 and concentrated. Purification by reversed phase HPLC (21×100 mm Phenomenex Gemini, 5-40% MeCN/water containing 0.1% TFA over 20 min at 20 mL/min) to give title compound as a white solid. Mass. found (M+H)+, 387.0.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08541595B2 |
|---|
| Source dataset | uspto-grants-2013_09 |
|---|
| ORD ID | ord-a398d753743c44eeb7ff93305f29071e |
|---|
| Source note | uspto-grants-2013_09 |
|---|